Oslo, Jan 17: Norwegian officials said 23 people had died in the country a short time after receiving their first dose of the Covid-19 vaccine. Of those deaths, 13 have been autopsied, with the results suggesting that common side effects may have contributed to severe reactions in frail, elderly people, according to the Norwegian Medicines Agency.
Search
Health & Food
Scientists have developed a rapid blood test that can predict within a day of hospitalisation which patients with COVID-19 are at the highest risk of severe complications or death, an advance that may help identify those who may best benefit from specific investigational treatments.
New Delhi, Jan 12: Amid the ongoing debate around the safety and efficacy aspects of Covid vaccines, the president of Indian Medical Association (IMA) has advised the public to not worry too much about it.
Chennai, Jan 8: A three-day national immunisation drive for polio will begin in the country on January 17, said Union Health Minister Dr Harsh Vardhan on Friday.
Washington, Jan 7: Nearly 4,400 adverse events were reported after people received the Pfizer-BioNTech COVID-19 vaccine in the US, with 21 cases determined to be anaphylaxis, according to a report by the Centers for Disease Control and Prevention (CDC).
Geneva, Jan 6: The 'UK' coronavirus variant had been detected in 41 countries/territories, the World Health Organization (WHO) said in a statement.
Geneva, Jan 5: As India launches the world's most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire population, two prominent Indian scientists at WHO have said.
New Delhi, Jan 2: India successfully cultures the new viral strain on the horizon (UK-variant of SARS-CoV-2), the Indian Council of Medical Research (ICMR) said, on Saturday.
New Delhi, Jan 2: India has approved the Covid-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunisation campaign in the world's second most populous country.
New Delhi, Jan 1: The 10-member Subject Expert Committee of India's Central Drug Standard Control Organisation on Friday approved emergency use authorisation of the Oxford-AstraZeneca coronavirus vaccine 'Covishield'.